PETMED EXPRESS, INC.

(PETS)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
21.78 USD   -0.77%
06/19PETMED EXPRESS : View the 2022 Proxy
PU
06/17PETMED EXPRESS : 2022 PetMed Express, Inc. Annual Report
PU
05/24PETMED EXPRESS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PETMED EXPRESS, INC. : Ex-dividend day for

05/19/2022 EDT

A dividend is removed today from PetMed Express, Inc.'s share.



© Factset 2022
All news about PETMED EXPRESS, INC.
06/19PETMED EXPRESS : View the 2022 Proxy
PU
06/17PETMED EXPRESS : 2022 PetMed Express, Inc. Annual Report
PU
05/24PETMED EXPRESS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
05/19PETMED EXPRESS, INC. : Ex-dividend day for
FA
05/10PETMED EXPRESS INC : Results of Operations and Financial Condition, Regulation FD Disclosu..
AQ
05/10PETMED EXPRESS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K..
AQ
05/10Morgan Stanley Adjusts PetMed Express' Price Target to $20 from $21, Keeps Underweight ..
MT
05/09PETMED : Fiscal Q4 Earnings Snapshot
AQ
05/09TRANSCRIPT : PetMed Express, Inc., Q4 2022 Earnings Call, May 09, 2022
CI
05/09PetMed Express Reports Lower Fiscal Q4 Earnings, Sales
MT
More news
Analyst Recommendations on PETMED EXPRESS, INC.
More recommendations
Financials (USD)
Sales 2023 286 M - -
Net income 2023 23,1 M - -
Net cash 2023 112 M - -
P/E ratio 2023 19,2x
Yield 2023 6,11%
Capitalization 440 M 440 M -
EV / Sales 2023 1,15x
EV / Sales 2024 1,11x
Nbr of Employees 212
Free-Float 95,3%
Chart PETMED EXPRESS, INC.
Duration : Period :
PetMed Express, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PETMED EXPRESS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 21,78 $
Average target price 24,00 $
Spread / Average Target 10,2%
EPS Revisions
Managers and Directors
Matthew N. Hulett President, Chief Executive Officer & Director
Bruce S. Rosenbloom Chief Financial Officer & Treasurer
Gian Mark Fulgoni Chairman
Mark Moseley Chief Technology & Information Officer
Ronald J. Korn Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PETMED EXPRESS, INC.-13.78%440
RAIA DROGASIL S.A.-19.09%6 256
AIN HOLDINGS INC.23.21%1 836
RITE AID CORPORATION-45.20%484
QOL HOLDINGS CO., LTD.-2.79%371
HLS THERAPEUTICS INC.-20.00%302